Skullcapflavone II Inhibits SLC1A4‐Mediated L‐Serine Uptake and Promotes Mitochondrial Damage in Gastric Cancer
Open Access
- 19 September 2025
- journal article
- Published by Wiley in Advanced Science
- Vol. 12 (45) , e17225
Abstract
Gastric cancer (GC) is one of the most lethal human malignancies worldwide. Serine metabolism is essential for meeting biosynthetic demands and regulating the redox state of GC cells. This study demonstrates that Skullcapflavone II (SkII) selectively inhibits the proliferation and metastasis of GC cells. Transcriptomic and metabolomic analyses reveal that SkII treatment significantly affects serine metabolism in GC cells, and isotope tracing experiments confirmed that SkII reduces intracellular L‐serine levels by inhibiting uptake rather than de novo synthesis. Furthermore, IHC analysis reveal significant upregulation of the L‐serine transporter SLC1A4 in GC tissues. Binding studies using PELSA, SPR, DARTS, CETSA, and MD suggest that SLC1A4 is a potential direct target of SkII. SkII‐induced disruption of serine metabolism resulted in an imbalance in GSSG/GSH, leading to increased accumulation of intracellular ROS and oxidative stress. This metabolic disruption causes mitochondrial damage, impaired energy production, and increased apoptosis in GC cells. Additionally, in vivo studies reveal that a serine and glycine deficient diet significantly enhanced the antitumor efficacy of SkII, highlighting its potential as a combinatorial therapeutic strategy. These findings provide compelling evidence that SkII is a novel candidate for targeting serine metabolism, suggesting a promising therapeutic approach for treating GC.Keywords
Funding Information
- National Natural Science Foundation of China (82422078)
- National Natural Science Foundation of China (82374544)
- National Natural Science Foundation of China (82204828)
- Natural Science Foundation of Zhejiang Province (LR24H290001)
- Natural Science Foundation of Zhejiang Province (LHDMY22H160008)
- Natural Science Foundation of Zhejiang Province (LQ23H310002)
This publication has 38 references indexed in Scilit:
- ASCT2 is a major contributor to serine uptake in cancer cellsCell Reports, 2024
- Amino acid transporters within the solute carrier superfamily: Underappreciated proteins and novel opportunities for cancer therapyMolecular Metabolism, 2024
- Blocking Ubiquitin‐Specific Protease 7 Induces Ferroptosis in Gastric Cancer via Targeting Stearoyl‐CoA DesaturaseAdvanced Science, 2024
- Serine Metabolic Reprogramming in Tumorigenesis, Tumor Immunity, and Clinical TreatmentAdvances in Nutrition, 2023
- Serine signaling governs metabolic homeostasis and healthTrends in Endocrinology & Metabolism, 2023
- Molecular pathogenesis, targeted therapies, and future perspectives for gastric cancerSeminars in Cancer Biology, 2022
- SHMT2-mediated mitochondrial serine metabolism drives 5-FU resistance by fueling nucleotide biosynthesisCell Reports, 2022
- Supply and demand: Cellular nutrient uptake and exchange in cancerMolecular Cell, 2021
- Redox metabolism: ROS as specific molecular regulators of cell signaling and functionMolecular Cell, 2021
- Neurons Release Serine to Support mRNA Translation in Pancreatic CancerCell, 2020